Skip to content
TidalSense logo — The respiratory intelligence company

TidalSense

The respiratory intelligence company

Founded 2013 United Kingdom Cambridge, United Kingdom 33 employees Venture round Total: $29.27M Biotechnology, Health Care

General Information

Company Name TidalSense
Founded Year 2013
Location United Kingdom Cambridge, United Kingdom
Employees 33
Industries Biotechnology, Health Care
Funding Stage Venture round
Business Model B2B, SaaS, B2G
Revenue Model Subscription, Product Sales, Tiered Pricing
Social

BounceWatch is an independent company data service, not affiliated with TidalSense. To contact TidalSense, visit tidalsense.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does TidalSense compare?

A PDF of TidalSense and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting TidalSense soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About TidalSense

TidalSense, known as The respiratory intelligence company, is carving a niche in the Biotechnology and Health Care industries. Founded in 2013 as Cambridge Respiratory Innovations, the company operates out of its headquarters in the United Kingdom.

TidalSense develops cutting-edge respiratory technology solutions, underpinned by its patented sensor technology, N-Tidal. This innovation delivers high precision and rapid CO2 sampling, offering unique insights into lung physiology. Their technology stands out for being the first of its kind in clinical medicine, marking significant advancements in AI-driven diagnostic and monitoring solutions for respiratory care.

The company secured a £2.54M Seed Round investment on 16 May 2023, with backing from reputable investors such as Foresight Group, Downing Ventures, and Business Growth Fund. This investment underscores faith in TidalSense's disruptive potential in respiratory medicine.

Business keywords: respiratory technology, AI-driven diagnostic, monitoring solutions, novel sensor technology, N-Tidal, lung physiology, CO2 monitoring, AI-driven respiratory technology, COPD diagnostic test, 4G connected device, portable technology, patient acceptability, clinical medicine, respiratory biomarkers

Services & Products

Diagnostic Testing for COPD
AI-Powered Monitoring Technologies
N-Tidal Diagnose CE-Marked Medical Device
Respiratory Intelligence Technologies

Target Customers

Healthcare Providers Pharmaceutical Companies Respiratory Patients

Funding Rounds & Investors (9)

View All
Funding Stage Amount Investors Lead Investors Date
Venture round $19.00M 5
Foresight Group, BGF +3
24 Jul 2026
Seed Round £2.54M 3
Foresight Group, Downing Ventures +1
16 May 2023
Seed Round £2.54M 2
Downing Ventures, Business Growth Fund
21 Oct 2021
Seed Round £2.54M 2
Downing Ventures, Business Growth Fund
18 Nov 2020
Pre Seed Round £722.00K -
20 May 2020
Grant Undisclosed 1
SBRI Healthcare
24 Jan 2018
Grant £932.75K 1
SBRI Healthcare
01 Nov 2016
Grant £84.80K 1
SBRI Healthcare
01 May 2014
Grant £915.92K -
01 Sep 2013

TidalSense Alternatives & Competitors

View All Alternatives
TidalSense vs
Quest Diagnostics
Quest Diagnostics United States

Working together to create a healthier world, one life at a time.

IPO
33096 employees
Biotechnology, Health Care
TidalSense vs
VIDA
VIDA United States

Modernizing Lung and Respiratory Care

Venture round
469 employees
AI, Biotechnology
TidalSense vs
Aevice Health
Aevice Health Singapore

Every step we take goes a long way towards helping patients breathe better.

Seed
18 employees
Biotechnology, Hardware

FAQ About TidalSense

The respiratory intelligence company
TidalSense was founded in 2013.
TidalSense is headquartered in Cambridge, United Kingdom.
TidalSense operates in Biotechnology and Health Care. Its work centres on respiratory technology, AI-driven diagnostic, monitoring solutions and novel sensor technology. Its customers include Healthcare Providers, Pharmaceutical Companies and Respiratory Patients.
TidalSense has a B2B, SaaS and B2G business model. Its revenue comes from Subscription, Product Sales and Tiered Pricing.
TidalSense has approximately 33 employees.
TidalSense has completed 9 funding rounds, raising a total of $29.27M. The latest funding stage is Venture round.
TidalSense offers: Diagnostic Testing for COPD, AI-Powered Monitoring Technologies, N-Tidal Diagnose CE-Marked Medical Device, Respiratory Intelligence Technologies.
Top alternatives and competitors to TidalSense include Quest Diagnostics, VIDA, Aevice Health, LungLife AI, Metabolomx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
TidalSense and Quest Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for TidalSense, https://bouncewatch.com/company/tidalsense, updated 25 September 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout